Simcere Pharmaceutical Co., Ltd
Clinical trials sponsored by Simcere Pharmaceutical Co., Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a simple tablet protect your brain after a stroke? Results expected Dec 2026 (estimated)
- New asthma drug aims to cut severe attacks in half Results expected Feb 2027 (estimated)
- New RSV drug for babies shows promise in phase 3 trial Results expected Mar 2027 (estimated)
-
New shot shows promise for tough eczema in phase 3 trial
Disease control CompletedThis study tested a biologic drug called SIM0718 in 259 adults and teens with moderate to severe atopic dermatitis (eczema) that did not respond well to creams. Participants received either the drug or a placebo every two weeks for 16 weeks. The goal was to see if the drug could …
Phase 3 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Healthy volunteers test new Drug's body processing
Knowledge-focused CompletedThis study tested how a new medicine called SIM0718 moves through the body in 178 healthy adults in China. Participants received a single injection, and researchers measured drug levels, safety, and immune reactions. The goal was to understand the drug's basic behavior before tes…
Phase 1 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC